{"schemaVersion":"ready-scan.discovery-entity.v3","id":"urn:readyscan:entity:enlivex-q96480089","slug":"enlivex-q96480089","kind":"entity","entityType":"Organization","canonicalUrl":"https://readyscan.ai/entities/enlivex-q96480089","machineUrl":"https://readyscan.ai/discovery/entities/enlivex-q96480089.json","llmsUrl":"https://readyscan.ai/entities/enlivex-q96480089/llms.txt","name":"Enlivex","alternateNames":[],"websiteUrl":"https://www.enlivex.com","category":{"slug":"wikidata-businesses","name":"Wikidata businesses","canonicalUrl":"https://readyscan.ai/directory/wikidata-businesses"},"description":"Israeli drug company, focused on Cell Immunotherapy","summary":"Enlivex — Wikidata Q96480089; Israeli drug company, focused on Cell Immunotherapy; source revision 2403514555, modified 2025-09-11T10:32:09Z.","localizedDescriptions":[],"claims":[{"id":"source-description","label":"Source description","value":"Israeli drug company, focused on Cell Immunotherapy","sourceIds":["source-record"]},{"id":"source-listed-website","label":"Source-listed website","value":"www.enlivex.com — https://www.enlivex.com","sourceIds":["source-record"]},{"id":"wikidata-item","label":"Wikidata item","value":"Wikidata Q96480089","sourceIds":["source-record"]},{"id":"source-revision","label":"Source revision","value":"2403514555, modified 2025-09-11T10:32:09Z","sourceIds":["source-record"]}],"sources":[{"id":"source-record","title":"Enlivex — Wikidata Q96480089","publisher":"Wikidata","url":"https://www.wikidata.org/wiki/Special:EntityData/Q96480089.json?revision=2403514555","accessedOn":"2026-07-29"},{"id":"source-attribution","title":"Wikidata data access","publisher":"Wikidata","url":"https://www.wikidata.org/wiki/Help:Data_access","accessedOn":"2026-07-29"},{"id":"permission-evidence","title":"Wikidata reuse permission","publisher":"Wikidata","url":"https://www.wikidata.org/wiki/Wikidata:Licensing","accessedOn":"2026-07-29"},{"id":"reuse-license","title":"CC0 1.0 Universal","publisher":"Wikidata","url":"https://creativecommons.org/publicdomain/zero/1.0/","accessedOn":"2026-07-29"}],"ownership":{"state":"public_sourced_unclaimed","notice":"Public-source record; owner verification is not claimed.","provenance":{"snapshotId":"wikidata-organization-frontier-2026-07-29","sourceId":"wikidata","sourceRecordId":"Q96480089","sourceRevisionId":"wdqs-sha256-3c17642f1bbfdea676527ee9fdfb40ac17a53047a47c16f94b486c07ab46b6e5","sourceContentHash":"fnv1a64:44c4becbd7af8292","recordRevisionId":"2403514555","recordContentHash":"fnv1a64:66b3a667373958d6","sourceCanonicalUrl":"https://www.wikidata.org/wiki/Special:EntityData/Q96480089.json?revision=2403514555","sourceModifiedAt":"2025-09-11T10:32:09Z","observedOn":"2026-07-29","permission":{"basis":"cc0","evidenceUrl":"https://www.wikidata.org/wiki/Wikidata:Licensing","license":{"spdxId":"CC0-1.0","name":"CC0 1.0 Universal","url":"https://creativecommons.org/publicdomain/zero/1.0/"}},"attributionUrl":"https://www.wikidata.org/wiki/Help:Data_access"}},"datePublished":"2026-07-29","dateModified":"2026-07-29","contentFingerprint":"fnv1a64:30b77649385a88a3","revision":"fnv1a64:d182741f446a6594","agentProtocol":{"discovery":"https://readyscan.ai/api/v1/ai-search/discovery","evidence":"https://readyscan.ai/api/v1/ai-search/entities/enlivex-q96480089/evidence","verification":"https://readyscan.ai/api/v1/ai-search/verify?entity=enlivex-q96480089"},"structuredData":{"@context":"https://schema.org","@id":"https://readyscan.ai/entities/enlivex-q96480089#entity","name":"Enlivex","identifier":"urn:readyscan:entity:enlivex-q96480089","description":"Israeli drug company, focused on Cell Immunotherapy","url":"https://www.enlivex.com","mainEntityOfPage":"https://readyscan.ai/entities/enlivex-q96480089","datePublished":"2026-07-29","dateModified":"2026-07-29","citation":["https://www.wikidata.org/wiki/Special:EntityData/Q96480089.json?revision=2403514555","https://www.wikidata.org/wiki/Help:Data_access","https://www.wikidata.org/wiki/Wikidata:Licensing","https://creativecommons.org/publicdomain/zero/1.0/"],"additionalProperty":[{"@type":"PropertyValue","propertyID":"ownership-state","name":"Ownership state","value":"public_sourced_unclaimed"},{"@type":"PropertyValue","propertyID":"content-fingerprint","name":"Material content fingerprint","value":"fnv1a64:30b77649385a88a3"},{"@type":"PropertyValue","propertyID":"source-record","name":"Source record","value":"wikidata/Q96480089"},{"@type":"PropertyValue","propertyID":"source-revision","name":"Source revision","value":"2403514555"},{"@type":"PropertyValue","propertyID":"reuse-license","name":"Reuse license","value":"CC0-1.0"},{"@type":"PropertyValue","propertyID":"claim:source-description","name":"Source description","value":"Israeli drug company, focused on Cell Immunotherapy"},{"@type":"PropertyValue","propertyID":"claim:source-listed-website","name":"Source-listed website","value":"www.enlivex.com — https://www.enlivex.com"},{"@type":"PropertyValue","propertyID":"claim:wikidata-item","name":"Wikidata item","value":"Wikidata Q96480089"},{"@type":"PropertyValue","propertyID":"claim:source-revision","name":"Source revision","value":"2403514555, modified 2025-09-11T10:32:09Z"}],"@type":"Organization"}}